Catalyst Capital Advisors’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2014
Q3 | – | Sell |
-3,000
| Closed | -$110K | – | 457 |
|
|
2014
Q2 | $110K | Hold |
3,000
| – | – | 0.02% | 317 |
|
|
2014
Q1 | $137K | Hold |
3,000
| – | – | 0.03% | 268 |
|
|
2013
Q4 | $117K | Hold |
3,000
| – | – | 0.04% | 232 |
|
|
2013
Q3 | $136K | Buy |
3,000
+1,500
| +100% | +$68K | 0.07% | 237 |
|
|
2013
Q2 | $74K | Buy |
+1,500
| New | +$74K | 0.06% | 240 |
|